Reversed-phase fused-core HPLC modeling of peptides

Matthias D'Hondt; Bert Gevaert; Sofie Stalmans; Sylvia Van Dorpe; Evelien Wynendaele; Kathelijne Peremans; Christian Burvenich

Volume 3 Issue 2

Apr. 2013

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2013 > 3(2): 93-101

Matthias D'Hondt, Bert Gevaert, Sofie Stalmans, Sylvia Van Dorpe, Evelien Wynendaele, Kathelijne Peremans, Christian Burvenich. Reversed-phase fused-core HPLC modeling of peptides[J]. Journal of Pharmaceutical Analysis, 2013, 3(2): 93-101.

Citation:

Matthias D'Hondt, Bert Gevaert, Sofie Stalmans, Sylvia Van Dorpe, Evelien Wynendaele, Kathelijne Peremans, Christian Burvenich. Reversed-phase fused-core HPLC modeling of peptides[J]. Journal of Pharmaceutical Analysis, 2013, 3(2): 93-101.

Citation:

Matthias D'Hondt, Bert Gevaert, Sofie Stalmans, Sylvia Van Dorpe, Evelien Wynendaele, Kathelijne Peremans, Christian Burvenich. Reversed-phase fused-core HPLC modeling of peptides[J]. Journal of Pharmaceutical Analysis, 2013, 3(2): 93-101.

PDF( 1951 KB)

Reversed-phase fused-core HPLC modeling of peptides

Drug Quality and Registration(DruQuaR)group, Faculty of Pharmaceutical Sciences, Ghent University,Harelbekestraat 72, B-9000 Ghent, Belgium
Departments of Medical Imaging and Physiology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133,B9820 Merelbeke, Belgium

Funds:

This research was funded by a Ph.D.grant of "Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)"

the Special Research Fund of the Ghent University